These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 15523550

  • 1. Telmisartan in the treatment of hypertension in patients with chronic renal insufficiency.
    Weinbergová O, Metelka R, Vymetal J, Konecný K, Kosatíková Z.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2004 Jul; 148(1):69-73. PubMed ID: 15523550
    [Abstract] [Full Text] [Related]

  • 2. Effect of telmisartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease.
    Rysavá R, Tesar V, Merta M, Czech Group for the Study of Glomerulonephritis.
    Blood Press Monit; 2005 Aug; 10(4):207-13. PubMed ID: 16077267
    [Abstract] [Full Text] [Related]

  • 3. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y, Neutel JM, Schumacher H.
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [Abstract] [Full Text] [Related]

  • 4. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y, Neutel JM, Davidai G, Koval S.
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [Abstract] [Full Text] [Related]

  • 5. Effects of telmisartan and ramipril on adiponectin and blood pressure in patients with type 2 diabetes.
    Delles C, Raff U, Mimran A, Fauvel JP, Ruilope LM, Schmieder RE.
    Am J Hypertens; 2008 Dec; 21(12):1330-6. PubMed ID: 18989258
    [Abstract] [Full Text] [Related]

  • 6. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
    Ucciferri C, Falasca K, Mancino P, Di Iorio A, Vecchiet J.
    Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876
    [Abstract] [Full Text] [Related]

  • 7. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
    Friedrich MG, Dahlöf B, Sechtem U, Unger T, Knecht M, Dietz R, TELMAR Investigators.
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours: a pooled analysis of the PRISMA I and II randomized trials.
    Williams B, Lacourcière Y, Schumacher H, Gosse P, Neutel JM.
    J Hum Hypertens; 2009 Sep; 23(9):610-9. PubMed ID: 19225530
    [Abstract] [Full Text] [Related]

  • 9. Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.
    Galle J, Schwedhelm E, Pinnetti S, Böger RH, Wanner C, VIVALDI investigators.
    Nephrol Dial Transplant; 2008 Oct; 23(10):3174-83. PubMed ID: 18450829
    [Abstract] [Full Text] [Related]

  • 10. Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients.
    Fogari R, Mugellini A, Zoppi A, Lazzari P, Destro M, Rinaldi A, Preti P.
    J Hum Hypertens; 2006 Mar; 20(3):177-85. PubMed ID: 16306998
    [Abstract] [Full Text] [Related]

  • 11. Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy.
    Masuda S, Tamura K, Wakui H, Kanaoka T, Ohsawa M, Maeda A, Dejima T, Yanagi M, Azuma K, Umemura S.
    Hypertens Res; 2009 Nov; 32(11):950-5. PubMed ID: 19713965
    [Abstract] [Full Text] [Related]

  • 12. Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor & angiotensin receptor blocker in type 1 DM with nephropathy.
    Anantharaman R, Bhansali A, Bhadada SK, Kohli HS, Dutta P, Walia R, Jayaprakash P, Upreti V.
    Indian J Med Res; 2010 Jul; 132():42-7. PubMed ID: 20693588
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of fixed dose combination (FDC) of telmisartan+ramipril usage in patients with micro-albuminuria and persistent hypertension: A TRIUMPH study.
    Sharma A, Baliga V, TRIUMPH Study Group.
    J Indian Med Assoc; 2008 Mar; 106(3):191-4, 196. PubMed ID: 18712142
    [Abstract] [Full Text] [Related]

  • 14. Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease.
    Nakamura T, Fujiwara N, Kawagoe Y, Sugaya T, Ueda Y, Koide H.
    Eur J Clin Invest; 2010 Sep; 40(9):790-6. PubMed ID: 20584070
    [Abstract] [Full Text] [Related]

  • 15. Effect of telmisartan on the proteinuria and circadian blood pressure profile in chronic renal patients.
    Cupisti A, Rizza GM, D'Alessandro C, Morelli E, Barsotti G.
    Biomed Pharmacother; 2003 Sep; 57(3-4):169-72. PubMed ID: 12818479
    [Abstract] [Full Text] [Related]

  • 16. Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study.
    Barnett AH.
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S42-9. PubMed ID: 15868119
    [Abstract] [Full Text] [Related]

  • 17. Reduction of proteinuria with angiotensin receptor blockers.
    Galle J.
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S36-43. PubMed ID: 18580865
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II receptor blocker telmisartan: effect on blood pressure profile and left ventricular hypertrophy in patients with arterial hypertension.
    Ivanova OV, Fomicheva OA, Sergakova LM, Chernova NA, Rogoza AN, Karpov YA.
    J Int Med Res; 2005 Jul; 33 Suppl 1():21A-29A. PubMed ID: 16222897
    [Abstract] [Full Text] [Related]

  • 19. Effects of dual blockade of renin-angiotensin system in type 2 diabetes mellitus patients with diabetic nephropathy.
    Krairittichai U, Chaisuvannarat V.
    J Med Assoc Thai; 2009 May; 92(5):611-7. PubMed ID: 19459520
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial.
    Zhu DL, Bays H, Gao P, Mattheus M, Voelker B, Ruilope LM.
    Clin Ther; 2012 Jul; 34(7):1613-24. PubMed ID: 22717420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.